Publication | Closed Access

Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma

Neuro-oncologyMedical ImagingMedicinePet-mriNeuroimagingRadiomicsHigh-grade GliomasMri-guided Radiation TherapyRadiation OncologyIsocitrate DehydrogenaseGliomaNuclear MedicineTumor AggressivenessMagnetic Resonance ImagingRadiologyHealth Sciences